Valuation GlaxoSmithKline plc LIQUIDNET SYSTEMS

Stocks

Delayed LIQUIDNET SYSTEMS Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-0.40%	-

07-30	Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US	RE
07-30	GSK global supply chain director sells 38,000 shares	AN

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	77,395	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	5.73%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	95,160	91,039	87,826
Change	-	-24.65%	-1.89%	-8.24%	28.83%	8.56%	-4.33%	-3.53%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	12.7x	11.3x	10.8x
PBR	5.34x	5.47x	4.4x	4.02x	-	7.3x	3.91x	3.38x
PEG	-	0x	-0.2x	-0.4x	0x	1.65x	0.9x	2.69x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.28x	2.17x	2.1x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.8x	2.56x	2.39x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.39x	7.23x	6.77x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.26x	8.16x	7.55x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	16.7x	14.9x	13.6x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	5.99%	6.7%	7.35%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6958	0.7315	0.7632
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.6%	3.79%	3.95%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.519	1.712	1.781
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	45.8%	42.7%	42.9%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,971	35,618	36,795
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,344	12,592	12,982
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,273	11,163	11,632
Net income ¹	4,385	14,956	4,928	2,575	5,716	6,138	6,958	7,126
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	17,765	13,643	10,431
Reference price ²	20.08	14.38	14.50	13.46	18.24	19.32	19.32	19.32
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	4,007,011	-	-
Announcement Date	2/9/22	2/1/23	1/31/24	2/5/25	2/4/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.03x	12.19x	25.61x	0.59%	1,024B
JOHNSON & JOHNSON	27.48x	6.29x	17.54x	2.1%	618B
ABBVIE INC.	32.57x	7.42x	15.35x	2.76%	443B
ROCHE HOLDING AG	19.7x	4.68x	11.59x	2.83%	349B
ASTRAZENECA PLC	21.76x	4.48x	12.7x	1.96%	264B
NOVO NORDISK A/S	13.48x	5.05x	10.4x	3.71%	209B
AMGEN INC.	25.29x	6.61x	11.66x	2.62%	208B
GILEAD SCIENCES, INC.	-46.92x	5.63x	31.08x	2.53%	162B
PFIZER INC.	12.69x	3.11x	7.86x	6.88%	143B
Average	15.68x	6.16x	15.98x	2.89%	379.88B
Weighted average by Cap.	24.04x	7.68x	18.14x	2.14%